Bumetanide Suppliers & Bulk Manufacturers
Available Forms: Tablet / Injection
Available Strengths: 0.5 mg, 1 mg, 2 mg, 0.25 mg/mL
Reference Brands: Bumex (USA), Burinex(EU)
Category:
Nephrology
Bumetanide is a potent loop diuretic that works by inhibiting sodium and chloride reabsorption in the loop of Henle, promoting rapid urine output. It is used to manage fluid retention (edema) due to heart failure, liver cirrhosis, or renal impairment, and sometimes for high blood pressure when other diuretics are insufficient. It acts faster and is more potent than furosemide.
Bumetanide is available in Tablet / Injection
and strengths such as 0.5 mg, 1 mg, 2 mg, 0.25 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Bumetanide is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Bumetanide can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing